Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - TOTAL ASSETS
Total Assets ALNY - Alnylam Pharmaceuticals, Inc.
4.24 B
LAST VALUE
9.34%
2 YEAR CAGR
12.10%
5 YEAR CAGR
14.66%
10 YEAR CAGR